Endothelial nitric oxide synthase (NOS3) is one of the enzymes influencing nitric oxide (NO) function in the human brain. NO is a gaseous neurotransmitter that is involved in a variety of mechanisms in the central nervous system, such as N-methyl-D-aspartate receptor activation and oxidative stress. The evidence from animal pharmacological studies and postmortem studies supports an association between NO and psychotic disorders. Methamphetamine (METH) use disorder is a known psychotic disorder, and we therefore conducted a gene-based case-control study between tagging single nucleotide polymorphisms (SNPs) (rs2070744, rs1799983) in NOS3 and METH-induced psychosis in Japanese subjects (183 with METH-induced psychosis and 267 controls). Written informed consent was obtained from each subject. No significant association was found between any tagging SNP in NOS3 and METH-induced psychosis in the allele/genotype-wise or haplotype-wise analyses. In conclusion, we suggest that NOS3 might not contribute to the risk of METH-induced psychosis in the Japanese population. ©2011 Bentham Science Publishers Ltd.
CITATION STYLE
Okochi, T., Kishi, T., Ikeda, M., Kitajima, T., Kinoshita, Y., Kawashima, K., … Iwata, N. (2011). Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese. Current Neuropharmacology, 9(1), 151–154. https://doi.org/10.2174/157015911795017119
Mendeley helps you to discover research relevant for your work.